Quest Diagnostics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell DGX and other ETFs, options, and stocks.

About DGX

Quest Diagnostics, Inc. engages in the provision of diagnostic testing, information, and services. It operates through the Diagnostic Information Services (DIS) and All Other segments. 

CEO
James E. Davis
CEOJames E. Davis
Employees
56,000
Employees56,000
Headquarters
Secaucus, New Jersey
HeadquartersSecaucus, New Jersey
Founded
1967
Founded1967
Employees
56,000
Employees56,000

DGX Key Statistics

Market cap
23.55B
Market cap23.55B
Price-Earnings ratio
24.13
Price-Earnings ratio24.13
Dividend yield
1.52%
Dividend yield1.52%
Average volume
957.40K
Average volume957.40K
High today
$213.50
High today$213.50
Low today
$208.97
Low today$208.97
Open price
$208.97
Open price$208.97
Volume
627.04K
Volume627.04K
52 Week high
$213.50
52 Week high$213.50
52 Week low
$157.20
52 Week low$157.20

Stock Snapshot

With a market cap of 23.55B, Quest Diagnostics(DGX) trades at $211.70. The stock has a price-to-earnings ratio of 24.13 and currently yields dividends of 1.5%.

During the trading session on 2026-02-27, Quest Diagnostics(DGX) shares reached a daily high of $213.50 and a low of $208.97. At a current price of $211.70, the stock is +1.3% higher than the low and still -0.8% under the high.

Trading activity shows a volume of 627.04K, compared to an average daily volume of 957.4K.

Over the past 52 weeks, Quest Diagnostics(DGX) stock has traded between a high of $213.50 and a low of $157.20.

Over the past 52 weeks, Quest Diagnostics(DGX) stock has traded between a high of $213.50 and a low of $157.20.

DGX News

TipRanks 1d
Quest Diagnostics names Benjamin Beauvalot VP, Chief Strategy and M&A Officer

Quest Diagnostics (DGX) announced that Benjamin Beauvalot has joined the company as SVP, Chief Strategy and M&A Officer. Prior to joining Quest, Beauvalot held...

Simply Wall St 3d
How Investors May Respond To Quest Diagnostics Earnings Beat, Higher Dividend And Expansion Plans

In February 2026, Quest Diagnostics reported higher fourth-quarter and full-year 2025 sales and earnings, issued 2026 guidance calling for US$11.70–US$11.82 bil...

How Investors May Respond To Quest Diagnostics Earnings Beat, Higher Dividend And Expansion Plans

Analyst ratings

52%

of 21 ratings
Buy
42.9%
Hold
52.4%
Sell
4.8%

People also own

Based on the portfolios of people who own DGX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.